Prestige Diagnostics
Private Company
Funding information not available
Overview
Prestige Diagnostics is a private, commercial-stage company operating in the diagnostics sector, generating revenue through product sales, distribution, and contract manufacturing. Its core expertise lies in IVD reagents, real-time PCR kits, and point-of-care diabetes testing, supported by an ISO 13485:2016 certified manufacturing facility. A key strategic advantage is its operational base in Northern Ireland, which under the NI Protocol provides unique regulatory and trade access to both the UK and EU markets, positioning it as a bridge for global IVD manufacturers.
Technology Platform
Integrated IVD manufacturing and regulatory expertise for reagents, assays (including real-time PCR), and point-of-care systems, with a specialization in HbA1c testing for diabetes management.
Opportunities
Risk Factors
Competitive Landscape
Prestige Diagnostics operates in the highly competitive global IVD market, competing against giants like Roche, Abbott, and Siemens Healthineers. It differentiates through agility, niche expertise in HbA1c, and its unique UK/EU regulatory positioning, acting as a specialist manufacturer and bridge for market access rather than competing head-on with broad portfolios.